A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Clinical trial NCT05818553 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05818553
Sponsor: Praxis Precision Medicines
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SCN2A Encephalopathy SCN8A Encephalopathy

Start date: 2023-08-02
Primary completion: 2025-11-12
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.